PATENT CLAIM ANALYSIS

Application Number: 15880889
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["424", "489000"]

Abstract:
The present disclosure provides for palonosetron formulations, such as aerosol formulations of palonosetron for pulmonary delivery. Also provided are uses of the formulation, such as reduction, elimination or prevention of nausea and vomiting associated with chemotherapy, radiation therapy, or surgery. Also provided are novel methods to treat chemotherapy-induced nausea and vomiting (CINV), radiation-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) using the inhalation formulations.

Claim (Index 53):
The formulation of  claim 1 , wherein the palonosetron or a pharmaceutically acceptable salt thereof is present in an amount of about 0.075 mg, about 0.25 mg, about 0.5 mg, or about 1 mg.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 86.0
- Lexical Diversity: 1.72917
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15154431', '15611785', '14855564', '14202262', '15351562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7000730018158922
- 35 USC 102 Novelty (BERT): 0.5327793857091436
- Combined Prediction Score: 0.6833436402052173
- Mean Citation Score: 231.746164
- Max Citation Score: 325.56503
- Similarity Product: 214.2019163436604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test